LENZ Therapeutics Inc.
(LENZ)
undefined
undefined%
At close: undefined
30.97
-0.08%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | 15.00M | - | - | - |
Cost of Revenue | 2.41M | 8.35M | 734.00K | 121.00K | - |
Gross Profit | -2.41M | 6.65M | -734.00K | -121.00K | - |
Operating Income | -73.11M | -105.64M | -60.44M | -13.50M | -29.00K |
Interest Income | 10.95M | - | - | - | - |
Pretax Income | -124.65M | -101.05M | -70.76M | -68.37M | -109.00K |
Net Income | -124.65M | -101.05M | -70.76M | -68.37M | -109.00K |
Selling & General & Admin | 40.97M | 32.85M | 21.78M | 4.26M | 29.00K |
Research & Development | 29.73M | 64.44M | 37.93M | 9.12M | - |
Other Expenses | - | 19.00K | -869.00K | - | - |
Operating Expenses | 70.70M | 97.29M | 59.71M | 13.38M | 29.00K |
Interest Expense | - | - | - | 40.00K | 80.00K |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 73.11M | 105.64M | 60.44M | 13.50M | 29.00K |
Income Tax | -124.65M | 347.00K | 497.44K | - | -171.86K |
Shares Outstanding (Basic) | 8.15M | 7.84M | 8.29M | 8.30M | 8.30M |
Shares Outstanding (Diluted) | 8.15M | 7.84M | 8.29M | 8.30M | 8.30M |
EPS (Basic) | -15.3 | -12.89 | -8.54 | -8.24 | -0.01 |
EPS (Diluted) | -15.3 | -12.89 | -8.54 | -8.24 | -0.01 |
EBITDA | -122.24M | -97.29M | -70.03M | -68.21M | -29.00K |
Depreciation & Amortization | 2.41M | 8.35M | 734.00K | 121.00K | 171.86K |